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Abstract
Background—Lesbian and bisexual women may be at greater risk of breast cancer than
heterosexual women during the premenopausal period due to disparities in risk factors.
Methods—With 16 years of prospective data from a large cohort of U.S. women ages 25–58
years, we conducted a breast cancer risk assessment for 87,392 premenopausal women by
applying the Rosner-Colditz biomathematical risk-prediction model to estimate breast cancer risk
based on known risk factors. Based on each woman’s comprehensive risk factor profile, we
calculated the predicted one-year incidence rate (IR) per 100,000 person-years and estimated
incidence rate ratios (IRR) and 95% confidence intervals (CI) for lesbian and bisexual women
compared to heterosexual women.
Results—87,392 premenopausal women provided 1,091,871 person-years of data included in
analyses. Mean predicted one-year breast cancer IRs per 100,000 person-years for each sexual
orientation group were: heterosexual 122.55, lesbian 131.61, and bisexual 131.72. IRs were
significantly elevated in both lesbian (IRR 1.06; 95 CI 1.06, 1.06) and bisexual (IRR 1.10; 95% CI
1.10, 1.10) women compared to heterosexual women.
Conclusions—Our findings suggest both lesbian and bisexual women have slightly elevated
predicted breast cancer incidence compared to heterosexual women throughout the premenopausal
period.
Impact—Health professionals must ensure that breast cancer prevention efforts are reaching these
women. As more health systems around the country collect data on patient sexual orientation, the
National Cancer Institute’s SEER cancer registry should add this information to its data system to
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monitor progress in reducing sexual orientation-related disparities in cancer incidence and
mortality.
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Introduction
Breast cancer is among the most commonly diagnosed cancers in U.S. women (1), and one
group that stands out as potentially at elevated risk is lesbian and bisexual women (2–7).
Recent research has identified a constellation of risk factors, including overweight,
nulliparity, and alcohol use, that may place lesbian and bisexual women at greater lifetime
risk than heterosexual women for developing breast cancer (8–10). Given the morbidity and
mortality associated with breast cancer in U.S. women and the evidence of disparities
adversely affecting lesbian and bisexual women, there is a need for new epidemiologic
research into the cancer risks in this underserved and understudied population.
There are few epidemiologic studies that are both large enough and include appropriate
measures of sexual orientation to provide data on sexual orientation patterns in breast cancer
incidence. For sociodemographic groups defined by age, sex, race/ethnicity, socioeconomic
status, and region of residence, the U.S. National Cancer Institute’s registry Surveillance
Epidemiology and End Results (SEER) gathers information needed to monitor cancer
incidence, mortality, and disparities by race/ethnicity, region, gender, and age. SEER does
not include information on sexual orientation in its data system, however, so this data source
contributes little to understanding of sexual orientation disparities in cancer incidence rates
and mortality (11, 12).
In lieu of SEER data on incidence rates, researchers have developed other approaches to
estimate breast cancer disparities associated with sexual orientation. Cochran et al.
compared self-reported breast cancer history among lesbian and bisexual women ages 18 to
75 in a pooled analysis of six surveys to similar self-report data collected from women in
National Health and Nutrition Examination Survey III (5). They did not find significant
differences in self-reported history of breast cancer. Boehmer et al. linked data on breast
cancer incidence rates from SEER to U.S. Census 2000 data on population density of female
same-sex partnered households, a proxy for lesbian population density, in the 215 counties
covered by the SEER registry (13). Based on their ecological analyses, the authors estimate
that a one-unit increase in the density of female same-sex partnered households in a county
is associated with a 13% higher rate of breast cancer cases, which is consistent with an
interpretation that lesbians may have elevated incidence of breast cancer compared to
heterosexual women.
Researchers have sought to compensate for inadequate national collection of incidence data
by estimating the risk of breast cancer in lesbian and bisexual women relative to
heterosexual women using mathematical modeling techniques. Three research teams have
used the Gail breast cancer risk model (14), a statistical method for calculating a woman’s
five-year and lifetime risk of breast cancer, to estimate orientation group differences in risk
(9, 15, 16). Dibble et al. applied the Gail model to data gathered from a California sample of
lesbians matched in dyads with their heterosexual sisters ages 40 years and older (mean age
49 years) (9), and Brandenburg et al. applied the Gail model to data from a sample of lesbian
and heterosexual women ages 18 to over 60 years old (mean age 43 years) recruited from
Chicago, New York City, and Minneapolis-St. Paul (16). Both studies estimated that
lesbians had a higher five-year and lifetime breast cancer risk compared to heterosexual
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women (9, 16). McTiernan and colleagues also applied the Gail model to estimate breast
cancer risk in a Seattle-based sample of lesbians compared to women in the general
population ages 18–74 years (mean age 42 years) but did not find lesbians to be at elevated
predicted risk (15). These studies were based on cross-sectional survey data, and none
estimated risk separately for bisexual women or for specific periods defined by age or
menopausal status.
While the Gail model has been shown to be a useful prediction tool for estimating breast
cancer risk (17), limitations of the model are that it does not fully account for exposure
effects that vary with time and reproductive status history and it overestimates risk in
premenopausal women by as much as twofold (18). It has become increasingly clear that
some exposures that affect breast cancer risk, particularly body mass index (BMI),
nulliparity, and age at first live birth, change in magnitude and, in some cases, direction of
effect over the life course (19–23). To account for these complex exposure-disease
relationships, the Rosner-Colditz risk prediction model has been developed as a risk
assessment tool to expand upon the Gail model to assess exposure effects that vary by time
and reproductive status history in a way that accounts for changes in both magnitude and
direction of effect for certain exposures (21, 24). In addition to risk factors considered in the
Gail model, the Rosner-Colditz model accounts for other important exposures, including
subsequent births following the first live birth, type of and age at menopause, height, current
weight, weight at age 18, and alcohol consumption (21, 24). The Rosner-Colditz model has
been found to perform better than the Gail model in estimating breast cancer risk in women
in a large prospective cohort study of women (18, 21, 24).
The Rosner-Colditz biomathematical model is based on the assumption that incidence of
breast cancer is proportional to the number of breast cell divisions accrued through the life
course up to a specified age (21, 24). The log of the rate of breast cell divisions is treated in
the mathematical model as a linear function of risk factors for breast cancer that have been
shown in prior research to be relevant at particular ages or periods in a woman’s life. The
regression coefficients corresponding to each risk factor included in the mathematical model
represent the effect of that risk factor at a particular age or period. Parameters for each
exposure in the model are interpreted as relative risks. Compared to conventional logistic
regression models, these models allow for more efficient testing of complex time-dependent
etiologic hypotheses.
Full consideration of exposures with time- and reproductive-status varying effects on disease
risk is critical for studies of lesbian and bisexual women because it is precisely these
exposures for which large sexual orientation group differences have been observed (8–10,
12). Importantly, evidence suggests that lesbian and bisexual compared to heterosexual
women experience higher rates of at least two risk factors – adiposity and nulliparity – that
have complicated time-variant implications for breast cancer (8–10, 12). The specific aim of
our study was to conduct a breast cancer risk assessment for premenopausal women of
diverse sexual orientations by applying the Rosner-Colditz risk prediction model to estimate
breast cancer risk as it evolves over time for each sexual orientation subgroup from age 25
to 58 years in a large, national longitudinal cohort of U.S. female nurses. We hypothesized
that lesbian and bisexual women would have higher predicted incidence of breast cancer. In
addition, we hypothesized that the risk disparity would be lower in the younger vs. older
premenopausal period due to anticipated accumulating effects of breast cancer risk factors
that are disproportionately prevalent in lesbian and bisexual women.
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In 1989, a baseline questionnaire was sent to approximately 520,000 registered nurses living
in 14 of the most populous U.S. states, leading to the enrollment of 116,430 women in the
Nurses’ Health Study (NHS) II(25). If a completed baseline questionnaire was returned, this
was considered an indication of informed consent for participation in the study. Since
baseline, questionnaires have been sent to the cohort every two years to gather information
on disease risk factors and disease incidence. At baseline, participants were ages 25–42
years old, and the racial/ethnic breakdown was 94% white, 2% African-American, 2%
Latina, and 2% Asian. Brigham and Women’s Hospital and Harvard School of Public Health
provided human subjects research approval.
Measures
In 1995, a measure of sexual orientation identity was added to the NHSII questionnaire (8),
reading: “Whether or not you are currently sexually active, what is your sexual orientation
or identity? (Please choose one answer)” with possible responses: 1) Heterosexual; 2)
Lesbian, gay or homosexual; 3) Bisexual; 4) None of these; 5) Prefer not to answer.
Heterosexual, lesbian, and bisexual women were included in this study.
Cancer History—An item asking if breast cancer has ever been diagnosed is included on
every NHSII questionnaire. The National Death Index is also routinely consulted to search
for deaths among women who did not respond to the questionnaires and so were unable to
provide information about diagnosis of the disease. Following receipt of consent from
participants or, for decedents, from a family member, all reports of cancer diagnosis are
confirmed through medical record review (19). Women were excluded from analyses once
they were diagnosed with any cancer other than non-melanoma skin cancer, though
observations were included up to the time of a reported diagnosis.
Information about family history of breast cancer has been collected in four survey years:
1989, 1997, 2001, and 2005. Participants were asked if any of their biological relatives had
been diagnosed with cancer of the breast. For breast cancer, participants are asked to
indicate if the relative was their mother, sister, or maternal or paternal grandmother. History
of benign breast disease was asked at each questionnaire cycle. Participants indicate whether
they have ever received a diagnosis of benign breast disease and, if so, if the diagnosis was
made more than 2 years prior to the survey date, during the two years between survey
cycles, or during the present year.
Height was recorded at baseline in 1989. Current weight was reported on every
questionnaire starting at baseline and weight at age 18 was reported once in 1989. The
validity of both self-reported current weight and weight at age 18 is strong (26, 27). Body
mass index (BMI) was calculated for each year of age using the standard formula of kg/m2
beginning from age 18 years. Alcohol use has been assessed almost every survey wave.
Participants report how many servings of alcohol they typically consumed per day and week
in the previous year separately for beer, wine, and liquor. At baseline, participants were also
asked to indicate their typical alcohol consumption in adolescence, young adulthood, and
adulthood prior to enrollment in the cohort. Pregnancy history is updated every
questionnaire. Data were collected separately for pregnancies six months or longer vs. those
lasting less than six months. Age at menarche was collected at baseline. Participants were
asked the age at which their menstrual periods began with the response options, “9 or less,
10, 11, 12, 13, 14, 15, 16, 17 or more.” Participants reported their menopausal status on each
questionnaire, indicating if their periods have ceased and, if yes, the reason, either naturally
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or due to hysterectomy with bilateral oophorectomy, hysterectomy with one ovary removed,
or hysterectomy (only uterus removed).
On the baseline questionnaire, women were asked to describe their ancestry choosing from a
list of provided categories, which were coded as white, African-American, Latina, Asian-
American, multiracial, and missing (28). Participants reported annual household income in
2001, which we then used to create four categories: Less than $50,000; $50,000 to less than
$75,000; $75,000 to less than $100,000; and $100,000 or greater. Region of residence was
updated each year a survey was returned and was coded as Northeast, South, Midwest, and
West.
Statistical Analyses
Our analytic sample included premenopausal women who were ages 25–58 years old when
they responded to biennial NHSII questionnaires administered from 1989 (baseline) to 2005.
Age 58 years was used as the upper age limit for these analyses to ensure sufficient sample
sizes of lesbian and bisexual women (the smallest subgroups) at the upper end of the age
range. Given the age distribution at baseline, only a small proportion of the cohort was older
than 58 years by the 2005 wave of data collection. Most variables included in the models
were either updated or cumulatively updated based on repeated measures of information.
When data for a variable were missing on a wave, information from prior waves was used to
carry forward values or cumulatively updated averages (29) were used, as appropriate. A
total of 87,392 (75.1% of the original cohort of 116,430) women provided 1,091,871 person-
years of data for our analyses.
We carried out a series of analytic steps using a modified version of the Rosner-Colditz risk
prediction model (21, 24). Because the oldest age included in analyses was 58 years, we did
not have sufficient data from women characterizing their exposures in the postmenopausal
period; therefore variables in the Rosner-Colditz model exclusively related to the
postmenopausal period, such as postmenopausal hormone use, were not included, and
women were excluded from analyses once they reached menopause. We used the modified
model first to generate predicted one-year breast cancer incidence rates (IR) per 100,000
person-years and then to examine sexual orientation group differences. For each year in
which a participant responded to a questionnaire, we calculated the predicted one-year breast
cancer IR based on each woman’s risk factor profile. This method allowed us to calculate
the model results for each woman multiple times (i.e., one time for each returned
questionnaire) using her updated risk factor profile each survey year (e.g., alcohol use
reported on current questionnaire, etc.) while also carrying forward risk factor information
reported on previous questionnaires as appropriate (e.g., BMI at age 18 years, age at first
birth, etc.). We estimated incidence rate ratios (IRR) and 95% confidence intervals (CI) for
lesbian and bisexual women compared to heterosexual women for all ages combined and
within each age strata (25–34 years, 35–44 years, and 45–58 years).
In additional analyses, the proportion of predicted IRs for lesbian and bisexual women
(separately) falling into each quintile was calculated, using cutoffs for risk quintiles based
on heterosexual women (the referent group) in the cohort. Quintile cutoffs were defined for
all age groups combined, and then separately for each of the three age strata. Note that by
design, 20% of predicted IRs from heterosexual women fell within each quintile; whereas
the proportion of predicted IRs from lesbian and bisexual women in each quintile could be
20% or could be higher or lower than 20%. Finally, we conducted ordinal logistic regression
to examine sexual orientation group differences in the distribution of predicted IRs across
the quintiles, controlling for sexual orientation, race/ethnicity, age, region of residence, and
household income. Ordinal logistic models were examined with all age groups combined
and generated odds ratios (OR) and 95% CI. Age-by-sexual orientation interactions were
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examined in the multivariable ordinal logistic regression model. We accounted for
correlated data resulting from repeated measures by using generalized estimating equation
(GEE) methods using the working correlation matrix (30).
Results
Sociodemographic characteristics of the 87,392 women included in analyses are presented in
Table 1. Lesbian and bisexual women made up roughly 1% of the cohort, and women of
color made up 6% of the cohort. Participants lived in all regions of the United States, and
about a third of the participants had an annual household income in 2001 of $100,000 or
greater. During the follow-up period, 1.8% (1592 cases) of heterosexual, 2.3% (15 cases) of
lesbian, and 1.9% (6 cases) of bisexual women were diagnosed with breast cancer (P=0.60;
not in table).
Table 2 presents sexual orientation group means and frequencies for important breast cancer
risk factors included in the Rosner-Colditz model for the premenopausal period. Compared
to heterosexual women, lesbian and bisexual women had significantly fewer births, higher
BMI and greater alcohol intake during premenopause, in addition to being older at baseline.
In addition, compared to heterosexual women, bisexual women were taller at baseline, and
lesbians had a higher prevalence of a history of benign breast disease.
Table 3 presents predicted incident cases of breast cancer in each sexual orientation group
for all ages and within age strata. Mean predicted one-year breast cancer IRs per 100,000
person-years for women of all ages in each sexual orientation group were: heterosexual
122.55, lesbian 131.61, and bisexual 131.72. IRs were significantly elevated in both lesbian
(IRR 1.06; 95 CI 1.06, 1.06) and bisexual (IRR 1.10; 95% CI 1.10, 1.10) women compared
to heterosexual women when combining across all ages. Findings were similar within each
age strata.
The Figure depicts the distribution of predicted breast cancer IR quintile membership of
bisexual and lesbian women with cutoffs for quintiles based on those for heterosexual
women. The distributions are first presented for each age strata (25–34 years, 35–44 years,
and 45–58 years), then presented for women ages 25–58 years combined. Interaction terms
for age-by-sexual orientation group were examined but were not statistically significant (P-
values>0.05), therefore they were not included in the final multivariable ordinal logistic
regression model estimating the odds of predicted breast cancer IR quintile membership for
bisexual and lesbian women relative to heterosexual women. Results from the final model
indicated that lesbian (OR 1.24; 95% CI 1.08, 1.41) and bisexual (OR 1.28; 95% CI 1.06,
1.56) women had elevated odds of being in a quintile group at higher risk of breast cancer
compared to heterosexual women of similar age, race/ethnicity, geographic region, and
household income (not in table).
Discussion
Breast cancer is a leading cause of morbidity and mortality in U.S. women (1), and efforts to
promote prevention are critically important. Previous epidemiologic research has identified
lesbian and bisexual women as potentially at elevated risk of breast cancer because of
comparatively high rates of overweight (for postmenopausal breast cancer), nulliparity, and
alcohol use relative to heterosexual women. Incidence of breast cancer in lesbian and
bisexual women, however, is not known because of the absence of sexual orientation
information in the nation’s SEER cancer registry and a lack of large prospective cohort
studies of adequate sample size with appropriate measures. In this context of limited
understanding of breast cancer disparities, we undertook the present study to apply the
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Rosner-Colditz risk prediction model to estimate predicted breast cancer incidence based on
comprehensive risk profiles of women of diverse sexual orientation. Consistent with our
hypotheses, findings suggest lesbian and bisexual women are at slightly elevated predicted
risk of breast cancer compared to heterosexual women throughout the premenopausal
period. Counter to our hypotheses, however, we did not find evidence that age modified the
association between sexual orientation and predicted breast cancer incidence during the
premenopausal years.
Findings from other studies applying the Gail model (14) to generate predicted incidence
estimates in lesbian and bisexual women have been variable. Three studies using the Gail
breast cancer risk model have examined sexual orientation group differences in risk
comparing lesbian and heterosexual women (9, 15, 16). Dibble et al.(9) and Brandenburg et
al.(16) both found lesbians to have higher five-year and lifetime predicted breast cancer risk,
while McTiernan et al. (15) did not find a sexual orientation-related difference in predicted
risk. Our study adds to this literature in several important ways. Our estimates were:
generated using the Rosner-Colditz model, which has been found to outperform the Gail
model (18, 21, 24); examined for specific premenopausal age periods (ages 25 to 58 years)
for which we had prospectively collected data; and provided separately for bisexual women.
As a result, our study provides the strongest evidence to date that lesbian and bisexual
women in the United States may experience breast cancer risk above that of heterosexual
women in the premenopausal period due to the disproportionate burden of known risk
factors in this population subgroup of women.
Several limitations of our study should be considered. Self-report survey data were used in
analyses, and the NHSII cohort is not a representative sample of U.S. women. White women
make up the vast majority of the cohort, and there were not sufficient subsample sizes of
lesbian and bisexual women of color to examine whether sexual orientation-related
disparities in predicted breast cancer risk estimated for the whole cohort are similar or
different within specific racial/ethnic subpopulations. Due to the age distribution of the
cohort, we did not have a sufficient number of observations from postmenopausal women,
so analyses had to be restricted to the premenopausal period. Given the important role of
exposures with time-varying effects on breast cancer and the marked increase in risk of
breast cancer after menopause, sexual orientation-related disparities in the postmenopausal
period may be different from those observed in our study. Because breast cancer risk
increases with age, the majority of cases occur in postmenopausal women; therefore, when
sample sizes are large enough and statistical power sufficient, it will be imperative that the
current study be extended to include the postmenopausal period.
Breast cancer is among the most commonly diagnosed cancers in U.S. women, and it is
well-documented that lesbian and bisexual women have comparatively high rates of known
risk factors for the disease. Our study, which applied the sophisticated Rosner-Colditz model
to the rich, prospective NHSII cohort data to estimate predicted breast cancer incidence
while accounting for time-variant exposure effects, now offers the strongest evidence to date
that lesbian and bisexual women may be disproportionately burdened by breast cancer. To
reduce these disparities, health professionals working in breast cancer prevention must
ensure that prevention efforts are reaching lesbian and bisexual women. In addition, as more
health systems around the country collect data on patient sexual orientation, the National
Cancer Institute’s SEER cancer registry should add this information to its data system to
monitor progress in reducing sexual orientation-related disparities in cancer incidence and
mortality.
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Figures 1a–d. Sexual orientation patterns in distribution of predicted breast cancer incidence
rates by risk quintiles in a U.S. cohort of women, ages 25–58 years and stratified by age
group 25–34, 35–44, and 45–58 years old*
*Predicted risk quintiles are based on distribution for heterosexual women within the
specified age range for Figures 1a–c and for heterosexual women ages 25–58 years for
Figure 1d.
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Table 1




 Heterosexual 98.89 86,418
 Lesbian 0.76 665
 Bisexual 0.35 309
Race/Ethnicity
 African American 1.40 1224
 Latina 1.37 1194
 Asian 1.56 1367
 White (non-Latina) 92.43 80,778
 Other 1.80 1572
Region of Residence
 Northeast 33.44 29,154
 Midwest 32.81 28,606
 South 18.46 16,092
 West 15.30 13,345
Household Income
 <50k 16.16 9965
 50–75k 27.55 16,988
 75–100k 21.24 13,100
 100k+ 35.05 21,611
*
Percentages and Ns calculated out of nonmissing.
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